Effects of rehabilitative training and anti-inflammatory treatment on functional recovery and cellular reorganization following stroke

Experimental Neurology

Volumn 233, Issue 2, 2012, Pages 776-782

  Liebigt, Susan ^a   Schlegel, Nadja ^a   Oberland, Julia ^a   Witte, Otto W ^a   Redecker, Christoph ^a   Keiner, Silke ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Indometacin; Minocycline; Sensorimotor cortex; Skilled reaching training

Indexed keywords

BROXURIDINE; INDOMETACIN; MINOCYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BRAIN INFARCTION; CELL MATURATION; CELL SUBPOPULATION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; FORELIMB; FUNCTIONAL ASSESSMENT; FUNCTIONAL TRAINING; HINDLIMB; IMMUNOCYTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL DIFFERENTIATION; NEUROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR CORTEX; THERAPY EFFECT; WALKING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMBINED MODALITY THERAPY; EXERCISE THERAPY; MALE; MOTOR CORTEX; PHYSICAL CONDITIONING, ANIMAL; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 84856558818     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.11.037     Document Type: Article

References (32)

1. Attur M.G., Patel R.N., Patel P.D., Abramson S.B., Amin A.R. Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide. J. Immunol. 1999, 162:3160-3167.
2. Biernaskie J., Corbett D. Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury. J. Neurosci. 2001, 21:5272-5280.
3. Bloch J., Kaeser M., Sadeghi Y., Rouiller E.M., Redmond D.E., Brunet J.F. Doublecortin-positive cells in the adult primate cerebral cortex and possible role in brain plasticity and development. J. Comp. Neurol. 2011, 519:775-789.
4. Chiu A.M., Chuenkongkaew W.L., Cornblath W.T., Trobe J.D., Digre K.B., Dotan S.A., Musson K.H., Eggenberger E.R. Minocycline treatment and pseudotumor cerebri syndrome. Am. J. Ophthalmol. 1998, 126:116-121.
5. Chu L.S., Fang S.H., Zhou Y., Yu G.L., Wang M.L., Zhang W.P., Wei E.Q. Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats. Acta Pharmacol. Sin. 2007, 28:763-772.
6. Chu L.S., Fang S.H., Zhou Y., Yin Y.J., Chen W.Y., Li J.H., Sun J., Wang M.L., Zhang W.P., Wei E.Q. Minocycline inhibits 5-lipoxygenase expression and accelerates functional recovery in chronic phase of focal cerebral ischemia in rats. Life Sci. 2010, 86:170-177.
7. Dawson T.M., Sasaki M., Gonzalez-Zulueta M., Dawson V.L. Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways. Prog. Brain Res. 1998, 118:3-11.
8. Dobkin B.H. Strategies for stroke rehabilitation. Lancet Neurol. 2004, 3:528-536.
9. Friel K.M., Nudo R.J. Recovery of motor function after focal cortical injury in primates: compensatory movement patterns used during rehabilitative training. Somatosens. Mot. Res. 1998, 15:173-189.
10. Godoy D.A., Biestro A., Puppo C. Does indomethacin cause cerebral ischemia?. Acta Anaesthesiol. Scand. 2005, 49:1577-1578.
11. Guerin C., Laterra J., Masnyk T., Golub L.M., Brem H. Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. Biochem. Biophys. Res. Commun. 1992, 188:740-745.
12. Hewlett K.A., Corbett D. Delayed minocycline treatment reduces long-term functional deficits and histological injury in a rodent model of focal ischemia. Neuroscience 2006, 141:27-33.
13. Hoehn B.D., Palmer T.D., Steinberg G.K. Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 2005, 36:2718-2724.
14. Jin K., Wang X., Xie L., Mao X.O., Greenberg D.A. Transgenic ablation of doublecortin-expressing cells suppresses adult neurogenesis and worsens stroke outcome in mice. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7993-7998.
15. Keiner S., Wurm F., Kunze A., Witte O.W., Redecker C. Rehabilitative therapies differentially alter proliferation and survival of glial cell populations in the perilesional zone of cortical infarcts. Glia 2008, 56:516-527.
16. Kriz J., Lalancette-Hebert M. Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol. 2009, 117:497-509.
17. Lampl Y., Boaz M., Gilad R., Lorberboym M., Dabby R., Rapoport A., Anca-Hershkowitz M., Sadeh M. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007, 69:1404-1410.
18. Liu Z., Fan Y., Won S.J., Neumann M., Hu D., Zhou L., Weinstein P.R., Liu J. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007, 38:146-152.
19. Matsukawa N., Yasuhara T., Hara K., Xu L., Maki M., Yu G., Kaneko Y., Ojika K., Hess D.C., Borlongan C.V. Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci. 2009, 10:126.
20. Metz G.A., Whishaw I.Q. Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination. J. Neurosci. Methods 2002, 115:169-179.
21. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., Vane J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:11693-11697.
22. Nagarajan L., Lam G.C. Tetracycline-induced benign intracranial hypertension. J. Paediatr. Child Health 2000, 36:82-83.
23. Rasmussen M. Treatment of elevated intracranial pressure with indomethacin: friend or foe?. Acta Anaesthesiol. Scand. 2005, 49:341-350.
24. Rogers D.C., Campbell C.A., Stretton J.L., Mackay K.B. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 1997, 28:2060-2065.
25. Samdani A.F., Dawson T.M., Dawson V.L. Nitric oxide synthase in models of focal ischemia. Stroke 1997, 28:1283-1288.
26. Saver J.L., Johnston K.C., Homer D., Wityk R., Koroshetz W., Truskowski L.L., Haley E.C. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. Stroke 1999, 30:293-298.
27. Stirling D.P., Khodarahmi K., Liu J., McPhail L.T., McBride C.B., Steeves J.D., Ramer M.S., Tetzlaff W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 2004, 24:2182-2190.
28. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z.J., Flegal K., O'Donnell C., Kittner S., Lloyd-Jones D., Goff D.C., Hong Y., Adams R., Friday G., Furie K., Gorelick P., Kissela B., Marler J., Meigs J., Roger V., Sidney S., Sorlie P., Steinberger J., Wasserthiel-Smoller S., Wilson M., Wolf P. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85-e151.
29. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 2001, 21:2580-2588.
30. Tsuji M., Wilson M.A., Lange M.S., Johnston M.V. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp. Neurol. 2004, 189:58-65.
31. Yong V.W., Wells J., Giuliani F., Casha S., Power C., Metz L.M. The promise of minocycline in neurology. Lancet Neurol. 2004, 3:744-751.
32. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13496-13500.